Cannabinoids and products

Medicinal cannabis in New Zealand is a regulated pharmaceutical pathway under the Misuse of Drugs Act, not a general licence to use cannabis. The Medicinal Cannabis Scheme, administered by the New Zealand Ministry of Health, legalises access through a prescription from a medical practitioner, and products must meet Good Manufacturing Practice (GMP) standards and be approved by the Ministry of Health. The thing newcomers most often get wrong is that “legal medicinal cannabis” does not mean a patient can legally smoke raw plant material or buy unregulated products; the legal product is a manufactured pharmaceutical. Raw flower, while available, is prescribed and dispensed through a pharmacy, not a dispensary.

This page is the overview. It explains what medicinal cannabis actually is, how the active compounds differ, and how the New Zealand regulatory system works. It then routes you to four focused guides for the details you need at each step of the patient pathway.

---

What medicinal cannabis is (and is not)

Medicinal cannabis in New Zealand is a regulated pharmaceutical pathway under the Misuse of Drugs Act, not a general licence to use cannabis. The scheme legalises access via a prescription from a medical practitioner, and products must meet GMP standards and be approved by the Ministry of Health. The thing newcomers most often get wrong is that “legal medicinal cannabis” does not mean a patient can legally smoke raw plant material or buy unregulated products; the legal product is a manufactured pharmaceutical, and the raw flower, while available, is prescribed and dispensed through a pharmacy, not a dispensary.

The scheme is managed by the Medicinal Cannabis Agency (MCA), part of Medsafe, which licences producers and importers and approves products for sale. Under the Misuse of Drugs Act, cannabis remains a controlled drug; the scheme creates a narrow, regulated exception for medical use. This page explains what those products are, how they differ, and how to navigate the system. It does not rank brands or give doses, that is the job of your prescriber.

Medicinal cannabis in New Zealand

Medicinal cannabis in New Zealand is a regulated pharmaceutical pathway, not a general licence to use cannabis. The Medicinal Cannabis Scheme, established under the Misuse of Drugs Act and administered by the Ministry of Health, legalises access only through a prescription from a medical practitioner. Products must meet Good Manufacturing Practice (GMP) standards and be approved by the Ministry of Health. The Medicinal Cannabis Agency (MCA), part of Medsafe, issues licences and manages the scheme.

The thing newcomers most often get wrong: “legal medicinal cannabis” does not mean a patient can legally smoke raw plant material or buy unregulated products. The legal product is a manufactured pharmaceutical. Even when dried flower is prescribed, it is dispensed through a pharmacy, not a dispensary, and patients cannot possess or use it outside the prescription framework. The Misuse of Drugs Act still governs possession, and the Medicinal Cannabis Scheme (under the Misuse of Drugs (Medicinal Cannabis) Regulations 2019, in force from 1 April 2020) creates a legal pathway only through a prescription from a medical practitioner.

This page explains what medicinal cannabis is, what the main cannabinoids do, how New Zealand’s scheme works, and how to choose between product types. It does not rank brands or give doses. For product-specific detail, see the four focused guides: Flower and oils, CBD products, THC products, and Quality and regulation.

---

What medicinal cannabis is in New Zealand

Medicinal cannabis in New Zealand is a regulated pharmaceutical pathway. It is not a general licence to use cannabis, nor a “natural remedy” exemption. The scheme was created by the Misuse of Drugs (Medicinal Cannabis) Amendment Act 2018, which came into force on 1 April 2020. Under the scheme, a medical practitioner can prescribe a manufactured cannabis product that meets Good Manufacturing Practice (GMP) standards and is approved by the Ministry of Health. The law change did not legalise raw plant material for smoking or make cannabis available without a prescription; it created a legal pathway for patients to access quality-assured pharmaceutical products through a pharmacy.

The thing newcomers most often get wrong is that “legal medicinal cannabis” does not mean a patient can legally smoke raw plant material or buy unregulated products. The legal product is a manufactured pharmaceutical, and the raw flower, while available, is prescribed and dispensed through a pharmacy, not a dispensary. In New Zealand, the Misuse of Drugs Act 1975 (and its 2018 amendment) governs this. The Medicinal Cannabis Scheme, administered by the Ministry of Health, came into force on 1 November 2020. Under the scheme, products must meet GMP standards and be approved by the Ministry of Health before they can be prescribed. The scheme does not legalise recreational use, and it does not allow patients to grow their own plants or buy from unregulated sellers. (Ministry of Health, 2020)

What is medicinal cannabis in New Zealand?

Under New Zealand’s Medicinal Cannabis Scheme, which was established by the Misuse of Drugs (Medicinal Cannabis) Amendment Act 2018 and fully operational from 1 April 2020, the Ministry of Health (through the Medicinal Cannabis Agency, part of Medsafe) regulates the scheme. Products must meet Good Manufacturing Practice (GMP) standards and be approved by the Ministry of Health before they can be prescribed and dispensed. The scheme is governed by the Misuse of Drugs Act 1975; it does not legalise recreational use and does not allow patients to grow their own plants or possess raw material without a prescription (New Zealand Ministry of Health, 2020).

The practical implication is that “medicinal cannabis” in New Zealand means a manufactured pharmaceutical product, not a herbal remedy. The raw flower is available, but only as a GMP-certified, pharmacy-dispensed prescription product. This distinction matters because many patients arrive expecting to buy dried plant material over the counter; that is not how the scheme works.

What is medicinal cannabis?

Medicinal cannabis is a regulated pharmaceutical pathway in New Zealand, established under the Misuse of Drugs (Medicinal Cannabis) Amendment Act 2018, which came into force in 2020. The scheme, administered by the Ministry of Health, allows medical practitioners to prescribe cannabis-based products that meet GMP standards and are approved by the Ministry of Health. It is not a general licence to use cannabis; the legal product is a manufactured pharmaceutical, and the raw flower, while available, is prescribed and dispensed through a pharmacy, not a dispensary. The key legal point is that “legal medicinal cannabis” under New Zealand’s Medicinal Cannabis Scheme does not mean a patient can legally smoke raw plant material or buy unregulated products. Products must meet Good Manufacturing Practice (GMP) standards and be approved by the Ministry of Health (New Zealand Ministry of Health, 2023).

The scheme is administered by the Medicinal Cannabis Agency (MCA), which sits within Medsafe. The agency licenses cultivators, manufacturers, and suppliers, and it maintains a public register of notified products. The Misuse of Drugs (Medicinal Cannabis) Regulations 2019 set the framework, and the scheme went live on 1 April 2020. Under that scheme, a medical practitioner can prescribe a CBD or THC product that meets GMP and quality standards, and the patient obtains it from a pharmacy with a prescription. The raw flower, when prescribed, is a manufactured pharmaceutical product dispensed through a pharmacy, not a recreational dispensary. The Misuse of Drugs Act still applies, and possession outside a prescription remains illegal. (New Zealand Ministry of Health, 2020; Medicinal Cannabis Agency, 2023)